California, USA (CU)_ Recent study indicates that targeted, localized, and applicable reprogramming of reactive macrophages can have a major influence on a variety of illnesses. According to Prof Rangaramanujam Kannan, a faculty member at the Johns Hopkins School of Medicine, Center for Nanomedicine, and Wilmer Eye Institute, delivering medications to specific cells at remote locations of damage is still a challenging task.
Hence, to overcome this massive challenge, he developed…
